Zobrazeno 1 - 10
of 60
pro vyhledávání: '"William D. Haire"'
Autor:
William D. Haire
Publikováno v:
Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66f331cf8a9e9b3add7122d0a9b67858
https://doi.org/10.1201/9780367812829-14
https://doi.org/10.1201/9780367812829-14
Publikováno v:
Journal of Thrombosis and Thrombolysis. 23:155-158
Dysfibrinogenemia is a disorder of fibrinogen structure and is associated with a functional abnormality. Since fibrinogen is a key component of both the procoagulant and fibrinolytic pathways, defects in fibrinogen function can be associated with inc
Autor:
Alex C. Spyropoulos, William D. Haire
Publikováno v:
Journal of Thrombosis and Thrombolysis. 15:227-232
New paradigms for the diagnosis, prophylaxis, acute treatment, and ongoing management of patients with venous thromboembolic disease (VTE), a better understanding of the genotypic and phenotypic mechanisms of thrombophilic states, and the possibility
Autor:
William D. Haire
Publikováno v:
Critical Care Medicine. 30:S257-S262
Objective: To review the data demonstrating that central nervous system, pulmonary, and hepatic dysfunctions during hematopoietic stem cell transplantation have similar laboratory correlates and clinical outcomes, suggesting that they are individual
Autor:
Steven Z. Pavletic, Timothy R. McGuire, EB Hoie, Stefano R. Tarantolo, William D. Haire, Gregory Bociek, James C. Lynch, L Hock, J. R. Schneider
Publikováno v:
Bone Marrow Transplantation. 28:889-893
Patients receiving high-dose preparation for stem cell transplantation are at risk for organ dysfunction (OD). Signs of early OD include hypoxia, mental status changes, and liver dysfunction. These early signs have not been correlated with potential
Autor:
William D. Haire
Publikováno v:
Techniques in Vascular and Interventional Radiology. 4:127-130
Dosing of thrombolytic agents for restoration of flow to thrombotically occluded central venous catheters has been empiric. The lowest effective dose of any agent is not known. Given that none of the dosing regimens in current use has ever been found
Autor:
William D. Haire, Suzanne L. Herbst
Publikováno v:
Nutrition in Clinical Practice. 15:265-275
Autor:
Z. S. Pavletic, Elizabeth C. Reed, James C. Lynch, Anne Kessinger, William D. Haire, Elizabeth Lyden, Stefano R. Tarantolo, Michael R. Bishop, Bruce Geoffrey Gordon
Publikováno v:
Bone Marrow Transplantation. 25:79-83
Development of CNS dysfunction in the setting of hematopoietic stem cell transplant (HSCT) has been previously shown to predict for subsequent second organ dysfunction and death. In this paper, we describe the characteristics of this isolated CNS dys
Autor:
Suzanne F. Herbst, William D. Haire
Publikováno v:
Journal of Vascular Access Devices. 5:28-36
Autor:
Julie M. Vose, James O. Armitage, Elizabeth I. Ruby, Anne Kessinger, Stefano R. Tarantolo, William D. Haire, Z. Steven Pavletic, Michael R. Bishop, L. C. Stephens, Philip J. Bierman, Elizabeth C. Reed
Publikováno v:
Biology of Blood and Marrow Transplantation. 4(3):142-150
Many of the complications of high-dose therapy with hematopoietic stem cells are caused by or lead to the multiple-organ dysfunction syndrome (MODS). In hematopoietic stem cell transplantation (HSCT), acquired antithrombin III (ATIII) deficiency is i